The REGEMAT 3D platforms are revolutionizing research in regenerative medicine and tissue engineering

The bioprinting solutions by REGEMAT 3D, distributed in Italy by Schaefer SEE Srl, continue to support researchers and institutions worldwide in developing new technologies for tissue regeneration and personalized medicine.

In recent months, several international research groups have published highly impactful scientific studies showing the use of the REGEMAT 3D bio-fabrication platforms in extremely varied applications: from bone regeneration to the healing of skin wounds, as well as the creation of vascular, cartilage and intestinal tissue models.

Recent publications that use REGEMAT 3D technology

Here are some of the most interesting projects::

• A Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen-Based Bioink for Skin Wound Healing
  Read the paper

• 3D-Printed Chitosan Devices for Bone Infections: An Antimicrobial and Osteogenic Platform
  Consult he paper on SSRN

• Design and Mechanical Characterization of Auxetic 2D Scaffolds and Application to Native Tissues
   DOI: 10.4028/p-R7pOuL

• Exploring the Rheological Properties of 3D Bioprinted Alginate-Based Hydrogels for Tissue Engineering
  Read here

• Establishing a Bioink Assessment Protocol: GelMA and Collagen in the Bioprinting of a Potential In Vitro Intestinal Model
  DOI: 10.1021/acsbiomaterials.5c00034

These publications – alongside many others – attest to the flexibility and reliability of REGEMAT 3D systems in supporting research on innovative bio-inks, hydrogels, custom scaffolds and biocompatible materials.

Each new study represents a step forward towards ever more targeted and personalized regenerative therapies, in line with the vision of REGEMAT 3D: make bio-fabrication accessible and adaptable to the needs of every laboratory.

Schaefer SEE Srl and Regemat3D offer technical support, training and consultancy to Italian researchers who wish to introduce 3D bioprinting into their projects.